USD 1.2
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 9.66 Million ILS | 190.97% |
2022 | 3.32 Million ILS | -4.18% |
2021 | 3.46 Million ILS | -57.09% |
2020 | 8.08 Million ILS | 4.1% |
2019 | 7.76 Million ILS | -53.83% |
2018 | 16.81 Million ILS | 12.64% |
2017 | 14.93 Million ILS | 45.56% |
2016 | 10.25 Million ILS | -38.5% |
2015 | 16.67 Million ILS | -58.08% |
2014 | 39.78 Million ILS | -34.39% |
2013 | 60.64 Million ILS | 24.05% |
2012 | 48.88 Million ILS | 133.46% |
2011 | -146.08 Million ILS | -180.38% |
2010 | 181.74 Million ILS | 17.9% |
2009 | 154.15 Million ILS | 24.61% |
2008 | 123.7 Million ILS | -33.86% |
2007 | 187.02 Million ILS | -6.2% |
2006 | 199.38 Million ILS | 108.18% |
2005 | 95.77 Million ILS | -45.72% |
2004 | 176.46 Million ILS | 3.89% |
2003 | 169.86 Million ILS | 3.27% |
2002 | 164.48 Million ILS | 51.66% |
2001 | 108.45 Million ILS | 16.72% |
2000 | 92.91 Million ILS | -25.31% |
1999 | 124.4 Million ILS | 967.89% |
1998 | 11.64 Million ILS | -98.19% |
1997 | 641.96 Million ILS | -0.55% |
1996 | 645.52 Million ILS | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 970.5 Thousand ILS | 0.0% |
2024 Q1 | 970.5 Thousand ILS | -76.68% |
2023 FY | 20.48 Million ILS | 516.31% |
2023 Q2 | 4.93 Million ILS | 0.0% |
2023 Q1 | 4.93 Million ILS | 272.25% |
2023 Q4 | 4.16 Million ILS | -21.63% |
2023 Q3 | 5.3 Million ILS | 7.69% |
2022 FY | 3.32 Million ILS | -4.18% |
2022 Q1 | 2.65 Million ILS | -65.96% |
2022 Q4 | 1.32 Million ILS | 0.0% |
2022 Q3 | 1.32 Million ILS | -50.1% |
2022 Q2 | 2.65 Million ILS | 0.0% |
2021 Q4 | 7.79 Million ILS | 0.0% |
2021 Q1 | 3.24 Million ILS | 4.47% |
2021 Q3 | 7.79 Million ILS | 139.98% |
2021 Q2 | 3.24 Million ILS | 0.0% |
2021 FY | 3.46 Million ILS | -57.09% |
2020 Q1 | 795 Thousand ILS | -95.18% |
2020 Q4 | 3.11 Million ILS | 0.0% |
2020 FY | 8.08 Million ILS | 4.1% |
2020 Q3 | 3.11 Million ILS | 291.26% |
2020 Q2 | 795 Thousand ILS | 0.0% |
2019 Q3 | 14.52 Million ILS | 379.31% |
2019 Q1 | 3.03 Million ILS | -91.65% |
2019 Q2 | 3.03 Million ILS | 0.0% |
2019 Q4 | 16.51 Million ILS | 13.64% |
2019 FY | 7.76 Million ILS | -53.83% |
2018 Q2 | 6.09 Million ILS | 0.0% |
2018 Q1 | 6.09 Million ILS | 17.15% |
2018 FY | 16.81 Million ILS | 12.64% |
2018 Q4 | 36.28 Million ILS | 655.38% |
2018 Q3 | 4.8 Million ILS | -21.13% |
2017 FY | 14.93 Million ILS | 45.56% |
2017 Q4 | 5.19 Million ILS | 0.0% |
2017 Q1 | 11.09 Million ILS | 271.92% |
2017 Q2 | 11.09 Million ILS | 0.0% |
2017 Q3 | 5.19 Million ILS | -53.16% |
2016 Q3 | 2.52 Million ILS | 17.23% |
2016 Q4 | 2.98 Million ILS | 18.23% |
2016 FY | 10.25 Million ILS | -38.5% |
2016 Q1 | 2.59 Million ILS | 98.55% |
2016 Q2 | 2.15 Million ILS | -17.1% |
2015 FY | 16.67 Million ILS | -58.08% |
2015 Q3 | 2.29 Million ILS | -43.55% |
2015 Q2 | 4.06 Million ILS | -3.38% |
2015 Q4 | 1.3 Million ILS | -42.96% |
2015 Q1 | 4.2 Million ILS | -64.77% |
2014 Q4 | 11.93 Million ILS | 52.27% |
2014 FY | 39.78 Million ILS | -34.39% |
2014 Q2 | 7.98 Million ILS | -16.46% |
2014 Q3 | 7.83 Million ILS | -1.88% |
2014 Q1 | 9.56 Million ILS | -43.16% |
2013 Q3 | 13.05 Million ILS | -15.27% |
2013 FY | 60.64 Million ILS | 24.05% |
2013 Q4 | 16.81 Million ILS | 28.78% |
2013 Q1 | 15.35 Million ILS | 177.9% |
2013 Q2 | 15.41 Million ILS | 0.4% |
2012 Q3 | 21.13 Million ILS | 101.68% |
2012 Q4 | -19.7 Million ILS | -193.24% |
2012 Q2 | 10.48 Million ILS | -59.39% |
2012 FY | 48.88 Million ILS | 133.46% |
2012 Q1 | 25.8 Million ILS | 110.64% |
2011 Q1 | 33.13 Million ILS | -59.73% |
2011 Q2 | 35.43 Million ILS | 6.94% |
2011 Q3 | 31.66 Million ILS | -10.62% |
2011 Q4 | -242.44 Million ILS | -865.55% |
2011 FY | -146.08 Million ILS | -180.38% |
2010 Q4 | 82.26 Million ILS | 170.41% |
2010 FY | 181.74 Million ILS | 17.9% |
2010 Q1 | 36.61 Million ILS | 156.1% |
2010 Q2 | 32.43 Million ILS | -11.41% |
2010 Q3 | 30.42 Million ILS | -6.21% |
2009 Q3 | 75.1 Million ILS | -78.77% |
2009 FY | 154.15 Million ILS | 24.61% |
2009 Q1 | 45.65 Million ILS | 73.19% |
2009 Q2 | 353.71 Million ILS | 674.84% |
2009 Q4 | 14.29 Million ILS | -80.96% |
2008 Q1 | 24.55 Million ILS | -73.5% |
2008 Q2 | 36.58 Million ILS | 49.01% |
2008 Q3 | 35.7 Million ILS | -2.42% |
2008 FY | 123.7 Million ILS | -33.86% |
2008 Q4 | 26.35 Million ILS | -26.18% |
2007 Q4 | 92.66 Million ILS | 200.88% |
2007 FY | 187.02 Million ILS | -6.2% |
2007 Q3 | 30.79 Million ILS | -5.89% |
2007 Q2 | 32.72 Million ILS | 6.39% |
2007 Q1 | 30.75 Million ILS | -52.88% |
2006 Q1 | 44.56 Million ILS | 116.19% |
2006 FY | 199.38 Million ILS | 108.18% |
2006 Q3 | 39.92 Million ILS | -19.29% |
2006 Q4 | 65.28 Million ILS | 63.51% |
2006 Q2 | 49.46 Million ILS | 11.0% |
2005 FY | 95.77 Million ILS | -45.72% |
2005 Q2 | 53.71 Million ILS | 9.31% |
2005 Q1 | 49.14 Million ILS | 2.46% |
2005 Q4 | 20.61 Million ILS | -18.88% |
2005 Q3 | 25.41 Million ILS | -52.69% |
2004 Q1 | - ILS | -100.0% |
2004 Q2 | 42.29 Million ILS | 0.0% |
2004 Q3 | 43.73 Million ILS | 3.39% |
2004 Q4 | 47.95 Million ILS | 9.67% |
2004 FY | 176.46 Million ILS | 3.89% |
2003 FY | 169.86 Million ILS | 3.27% |
2003 Q3 | 45.21 Million ILS | 6.84% |
2003 Q1 | 35.96 Million ILS | -27.02% |
2003 Q2 | 42.32 Million ILS | 17.7% |
2003 Q4 | 50.99 Million ILS | 12.76% |
2002 Q4 | 49.27 Million ILS | 22.92% |
2002 Q1 | 35.71 Million ILS | 10.24% |
2002 Q2 | 43.73 Million ILS | 22.46% |
2002 FY | 164.48 Million ILS | 51.66% |
2002 Q3 | 40.08 Million ILS | -8.34% |
2001 Q2 | - ILS | -100.0% |
2001 FY | 108.45 Million ILS | 16.72% |
2001 Q4 | 32.39 Million ILS | 34.13% |
2001 Q3 | 24.15 Million ILS | 0.0% |
2001 Q1 | 25.56 Million ILS | 27301.31% |
2000 Q2 | 27.98 Million ILS | 5.1% |
2000 Q1 | 26.62 Million ILS | 106.29% |
2000 Q3 | 33.72 Million ILS | 20.53% |
2000 FY | 92.91 Million ILS | -25.31% |
2000 Q4 | 93.3 Thousand ILS | -99.72% |
1999 Q3 | - ILS | 0.0% |
1999 Q2 | - ILS | 0.0% |
1999 Q1 | - ILS | 100.0% |
1999 Q4 | -423.56 Million ILS | 0.0% |
1999 FY | 124.4 Million ILS | 967.89% |
1998 Q2 | - ILS | 0.0% |
1998 FY | 11.64 Million ILS | -98.19% |
1998 Q1 | - ILS | 100.0% |
1998 Q4 | -11.64 Million ILS | 0.0% |
1998 Q3 | - ILS | 0.0% |
1997 FY | 641.96 Million ILS | -0.55% |
1997 Q1 | - ILS | 100.0% |
1997 Q4 | -1.7 Billion ILS | 0.0% |
1997 Q2 | - ILS | 0.0% |
1997 Q3 | - ILS | 0.0% |
1996 Q2 | - ILS | 0.0% |
1996 FY | 645.52 Million ILS | 0.0% |
1996 Q3 | - ILS | 0.0% |
1996 Q1 | - ILS | 0.0% |
1996 Q4 | -1.66 Billion ILS | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AVITA Medical, Inc. | 80.77 Million USD | 88.03% |
Manhattan Scientifics, Inc. | 703 Thousand USD | -1275.391% |
Össur hf. | 396.18 Million USD | 97.559% |
QHSLab, Inc. | 961.65 Thousand USD | -905.456% |
Wellstar International, Inc. | 1.79 Million USD | -438.754% |
Össur hf. | 396.18 Million USD | 97.559% |
CVR Medical Corp. | - USD | -Infinity% |
Bionovate Technologies Corp | - USD | -Infinity% |
Escalon Medical Corp. | 5.25 Million USD | -84.148% |
Aurora Spine Corporation | 8.65 Million USD | -11.684% |
BrainsWay Ltd. | 28.01 Million USD | 65.49% |
Lattice Biologics Ltd. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | -1205.429% |
Hamilton Thorne Ltd. | 33.57 Million USD | 71.2% |
Vivos Inc. | 2.78 Million USD | -246.918% |
Kelyniam Global, Inc. | 2.27 Million USD | -324.965% |
REMSleep Holdings, Inc. | 1.01 Million USD | -852.702% |
Zecotek Photonics Inc. | 3.46 Million USD | -179.334% |
Avitar, Inc. | 3.56 Million USD | -170.877% |
Nanomix Corporation | 8.36 Million USD | -15.551% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 55.602% |
Theraclion SA | 7.43 Million USD | -29.963% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Positron Corporation | 1 Million USD | -859.907% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | -210.856% |
Lombard Medical, Inc. | 30.29 Million USD | 68.079% |
ALR Technologies Inc. | 6.33 Million USD | -52.604% |
Stratec SE | 46.32 Million USD | 79.126% |
Vycor Medical, Inc. | 1.27 Million USD | -658.078% |
Heart Tronics, Inc. | 14.46 Million USD | 33.133% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.078% |
VMS Rehab Systems, Inc. | 63.63 USD | -15195562.423% |
NewCardio, Inc. | 9.56 Million USD | -1.094% |
Guided Therapeutics, Inc. | 3.49 Million USD | -176.811% |
Ingen Technologies, Inc. | 1.88 Million USD | -413.702% |
Odyssey Group International, Inc. | -14.26 Million USD | 167.8% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | -2120.207% |
Wellness Center USA, Inc. | 1.29 Million USD | -646.884% |
SANUWAVE Health, Inc. | 14.15 Million USD | 31.673% |
IR-Med Inc. | 4.89 Million USD | -97.568% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -4584.162% |
Polarean Imaging plc | 12.24 Million USD | 21.021% |
United American Healthcare Corporation | 59 Thousand USD | -16288.136% |
ECGI Holdings, Inc. | 407.48 Thousand USD | -2272.848% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -7922.335% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | -1423.426% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | -470.252% |
Medical Supply International USA, Inc. | 1.32 Million USD | -632.225% |
Urologix, Inc. | 10.09 Million USD | 4.191% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -665.356% |
Nexeon MedSystems Inc. | 5.94 Million USD | -62.551% |
SS Innovations International, Inc. | 21.38 Million USD | 54.779% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -4099.513% |
Smith & Nephew plc | 3.46 Billion USD | 99.721% |
NIOX Group Plc | 22.27 Million USD | 56.597% |
Fuse Medical, Inc. | 10.35 Million USD | 6.58% |
Broncus Holding Corporation | 38.15 Million USD | 74.656% |
Brain Scientific Inc. | 9.66 Million USD | -0.065% |
Pressure BioSciences, Inc. | 10.3 Million USD | 6.153% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -15829.685% |